Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Coffee May Protect Against Endometrial Cancer

By LabMedica International staff writers
Posted on 06 Dec 2011
Long-term coffee consumption may be linked with a decreased risk for endometrial cancer, according to new findings.

Edward Giovannucci, MD, ScD, professor of nutrition and epidemiology at the Harvard School of Public Health (Boston, MA, USA), reported that coffee is emerging as a protective agent in cancers that are linked to obesity, estrogen, and insulin. More...
“Coffee has already been shown to be protective against diabetes due to its effect on insulin,” said Dr. Giovannucci, a senior investigator on the study. “So we hypothesized that we’d see a reduction in some cancers as well.”

Dr. Giovannucci, working with Youjin Je, a doctoral candidate in his lab, and colleagues tracked cumulative coffee intake in relation to endometrial cancer in 67,470 women who enrolled in the Nurses’ Health Study. During the course of 26 years of follow-up, researchers documented 672 cases of endometrial cancer. Drinking more than four cups of coffee per day was associated with a 25% reduced risk for endometrial cancer. Drinking between two and three cups per day was linked with a 7% reduced risk. A comparable link was seen in decaffeinated coffee, where drinking more than two cups per day was associated with a 22% reduced risk for endometrial cancer. Dr. Giovannucci states that he hopes this study will lead to additional inquiries about the effect of coffee on cancer because in this and similar studies, coffee intake is self-selected and not randomized.
“Coffee has long been linked with smoking, and if you drink coffee and smoke, the positive effects of coffee are going to be more than outweighed by the negative effects of smoking,” said Dr. Giovannucci. “However, laboratory testing has found that coffee has much more antioxidants than most vegetables and fruits.”

The study’s findings were published online on November 22, 2011, in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Related Links:

Harvard School of Public Health



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.